Skip to main content

Table 1 Macronutrient intakes

From: Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use

Variable T1 T2 T3 Time*group Time*group*gender
kcal/d
 PLA 2054 ± 700 2132 ± 822 2128 ± 778 Time p = 0.11 G*T*Ge p = 0.17
 LD 2469 ± 727 2450 ± 957 2155 ± 563 G*T p = 0.39
 HD 2478 ± 1252 2395 ± 1139 2031 ± 763
Fat g/d
 PLA 85 ± 30 83 ± 32 92 ± 50 Time p = 0.89 G*T*Ge p = 0.41
 LD 101 ± 47 105 ± 50 104 ± 30 G*T p = 0.42
 HD 100 ± 60 94 ± 55a 83 ± 35a
Protein g/d
 PLA 106 ± 32 94 ± 28 96 ± 36 Time p  = 0.04 G*T*Ge p = 0.40
 LD 108 ± 62 101 ± 46 90 ± 34 G*T p = 0.48
 HD 110 ± 69 108 ± 57 83 ± 48
Carb g/d
 PLA 223 ± 109 320 ± 297 234 ± 91 Time p = 0.23 G*T*Ge p = 0.37
 LD 284 ± 102 284 ± 119 266 ± 89 G*T p = 0.52
 HD 282 ± 127 280 ± 148 235 ± 102
  1. Abbreviations: PLA Placebo, LD Theacrine Low Dose, HD Theacrine High Dose, G Group, T Time, Ge Gender
  2. Superscript letters, different letters are significantly different at a given time point (p < 0.05). Items in bold indicate a significant effect (p < 0.05) was observed
Back to article page